*The search scope is limited to the products and news section of this site
*The search scope is limited to the products and news section of this site
The next-generation "small molecule drug" + "novel toxin" dual-platform project independently developed by Genuine Biotech will be presented at the AACR annual meeting as "Late-Breaking Research".
Recently, at the BIOCHINA 2025 10th International Convention, the BIOCHINA Awards 2024 List was announced. Genuine Biotech, with its breakthrough R&D achievements, won the "2024 Innovation Breakthrough Enterprise Award".
On Feb. 2, Wang Zhaoyang, founder of Genuine Biotech, was invited to the new year government-enterprise exchange conference held by the CPC Henan Province Committee and the People's Government of Henan Province.
Copyright © 2022 河南真实生物科技有限公司 All Rights Reserved 京ICP备2021026784号-1
